Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Current Proteomics
Title: Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)]
Volume: 7 Issue: 3
Author(s): Qing-Yu He
Affiliation:
Keywords: Glycosite Analysis, Glycoproteomics, Mass Spectrometry, Glycosite, Enrichment, De-glycosylation, Intact glycopeptides, Quantification, Collision-inducced dissociation (CID), Electron transfer dissociation (ETD), Multistage tandem MS (MSn), Post-translational modifications, Covalent modifications, Numerous Cellular Processes, Glycoproteins, Post Proteomic er, N-linked glycans, Sugar structure elucidation, Micro-heterogeneity, Coexisting non-glycoproteins/peptides, Mammalian lectins, Galectins, selectins, Chemo-enzymatic labeling, De-Glycosylation Methods, O-GlcNAc modifcation, Beta-elemination, Michael addition, Dithiothreitol, Multiple lectin-mediated, Hydrazide chemistry, Non-redundant glycoproteins, Subproteome, O-GlcNAc Site, Mucin-type O-Glycosites, Electron Capture Dissociation (ECD), Infrared multiphoton dissociation (IRMPD), ETD/ECD Assisted Glycosite, Labeling based Quantification, Label-free Quantification, Immuno-enriched, BAP= Biotin pentylamine, ESI=Electrospray ionization, CDK=Climatic droplet keratopathy, CSC=Cell surface capturing, CRC=Colorectal cancer
Export Options
About this article
Cite this article as:
He Qing-Yu, Editorial:[Special Issue: Post-Translational Proteomics and its Application (Guest Editor: Qing-Yu He)], Current Proteomics 2010; 7 (3) . https://dx.doi.org/10.2174/157016410792928170
DOI https://dx.doi.org/10.2174/157016410792928170 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Future Targets for Immune Therapy in Colitis?
Endocrine, Metabolic & Immune Disorders - Drug Targets Epigenetic Therapies of Cancer
Current Cancer Therapy Reviews Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Current Drug Targets Lipid-Based Drug Delivery Systems for Cancer Treatment
Current Drug Targets Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies
Medicinal Chemistry Cetuximab, A Chimeric Anti-Epidermal Growth Factor Receptor Monoclonal Antibody, in Colorectal Cancer Treatment
Current Cancer Therapy Reviews KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Lgr5 Contributes to Intestinal Metaplasia During Gastric Carcinogenesis: A Meta analysis
Anti-Cancer Agents in Medicinal Chemistry Fullerenes for Applications in Biology and Medicine
Current Medicinal Chemistry V. Amygdalina: Folk Medicine, Analysis, and Potential Application for Cancer Treatment
Current Pharmaceutical Analysis Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
Current Chemical Biology Anti-Cancer Activity of Curcumin on Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Diabetes, Cancer and Treatment – A Mini-Review
Current Drug Safety Investigation of Binding Characteristics of Phosphoinositide-dependent Kinase-1 (PDK1) Co-crystallized Ligands Through Virtual Pharmacophore Modeling Leading to Novel Anti-PDK1 Hits
Medicinal Chemistry T-Cell Zeta Chain Expression, Phosphorylation and Degradation and their Role in T-Cell Signal Transduction and Immune Response Regulation in Health And Disease
Current Signal Transduction Therapy FBP1, A Tumor Suppressor and Negative Regulator of Glycolysis, was Epigenetically Silenced in Pancreatic Cancer
Current Signal Transduction Therapy Screening of Drug Efficacy of Rosmarinic Acid Derivatives as Aurora Kinase Inhibitors by Computer-Aided Drug Design Method
Current Computer-Aided Drug Design Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Current Clinical Pharmacology iNOS/COX-2 Pathway Interaction: A Good Molecular Target for Cancer Treatment
Current Enzyme Inhibition The Pharmacogenomics “Side-effect” of TP53/EGFR in Non-small Cell Lung Cancer Accompanied with Atorvastatin Therapy: A Functional Network Analysis
Anti-Cancer Agents in Medicinal Chemistry